Access

News and Views


Nature Medicine 8, 13 - 14 (2002)
doi:10.1038/nm0102-13

The microarray way to tailored cancer treatment

Laura J. Van't Veer1 & Daphne De Jong1

  1. The Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital Amsterdam, the Netherlands
    e-mail: lveer@nki.nl or e-mail: djong@nki.nl


Indistinguishable disease states in diffuse large B-cell lymphoma unraveled by microarray expression profiles: A new basis for therapy selection. (pages 68–74)


Fresh avenues of cancer diagnosis and therapy are opening up. They are made possible by putting together traditional clinical and pathological assessments of tumor status with the results of microarray analysis.

MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated

REVIEWS
Advantages and limitations of microarray technology in human cancer
Oncogene Reviews (29 Sep 2003)
Current trends in large cell lymphoma
Leukemia Reviews (01 Oct 2003)
 See all 5 matches for Reviews

NEWS AND VIEWS
Cancer: Gene expression in diagnosis
Nature News and Views (03 Feb 2000)
Microarrays--the 21st century divining rod?
Nature Medicine News and Views (01 Jun 2001)

RESEARCH
Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning
Nature Medicine Article (01 Jan 2002)